UNC Health Medication Formulary
Change Request Form Chemical/SDS Search UNC Health.org
QR Code Add Formweb to your mobile device
Android iOS
Click here to submit safety event reports via SAFE
UNC Health Medication Formulary
Change Request Form Chemical/SDS Search UNC Health.org
Search results for:

onasemnogene abeparvovec

onasemnogene abeparvovec
Drug Name Form Strength ARHS Blue Ridge Caldwell Chatham Johnston Lenoir Medical Center Nash Pardee Rex Rockingham Southeastern Wayne Youth Behavioral Health
Onasemnogene Abeparvovec (Zolgensma) KIT, INTRAVENOUS Kit                      
Onasemnogene Abeparvovec (Itvisma) SUSPENSION, INTRATHECAL brve 40 trillion vg/mL                          

UNC Health 

 System Formulary Restriction:

Itvisma is restricted to the following:

  • Ordered by neurology attending
  • SMA type 2 and non-ambulatory 3 patients
  • Anti-AAV9 antibody test < 1:50
  • Single case agreement or pre-authorization approved

Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies

Med Center
     UNC Medical Center Formulary Restrictions
     Onasemnogene Abeparvovec-xioi (Zolgensma) Ordering Process

Last updated: Jul. 23, 2026






This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved